See the original post: Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
See the original post: Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
Read the original post: Avenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol
Read more: Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
See more here: Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting
Read the original here: Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International...
Read more: Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®
Excerpt from: Adaptive Research Appoints Kristin Andruska, MD, PhD as Senior Medical Director and Clinical Neuroscience & Scientific Research Director
Go here to read the rest: Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process
Read more here: Intrommune Therapeutics Completes Last Patient Last Visit in the Phase 1 OMEGA Study for Peanut Allergy
Recent Comments